{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:20:34Z","timestamp":1790742034446,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s40257-020-00504-4","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T01:13:42Z","timestamp":1582074822000},"page":"579-590","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8158-660X","authenticated-orcid":false,"given":"Errol P.","family":"Prens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida M.","family":"Lugo-Somolinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Kerdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique D.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Longcore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa B.","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"issue":"2","key":"504_CR1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","volume":"366","author":"GB Jemec","year":"2012","unstructured":"Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158\u201364.","journal-title":"N Engl J Med"},{"issue":"5 Suppl 1","key":"504_CR2","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jaad.2015.07.047","volume":"73","author":"HH van der Zee","year":"2015","unstructured":"van der Zee HH, Jemec GB. New insights into the diagnosis of hidradenitis suppurativa: clinical presentations and phenotypes. J Am Acad Dermatol. 2015;73(5 Suppl 1):S23\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"504_CR3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","volume":"153","author":"A Garg","year":"2017","unstructured":"Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017;153(8):760\u20134.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"504_CR4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaad.2012.07.027","volume":"68","author":"I Cosmatos","year":"2013","unstructured":"Cosmatos I, Matcho A, Weinstein R, Montgomery MO, Stang P. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013;68(3):412\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"504_CR5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2230.2001.00876.x","volume":"26","author":"RA Palmer","year":"2001","unstructured":"Palmer RA, Keefe M. Early-onset hidradenitis suppurativa. Clin Exp Dermatol. 2001;26(6):501\u20133.","journal-title":"Clin Exp Dermatol."},{"issue":"2","key":"504_CR6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaad.2009.03.043","volume":"61","author":"L Matusiak","year":"2009","unstructured":"Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa and associated factors: still unsolved problems. J Am Acad Dermatol. 2009;61(2):362\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"504_CR7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","volume":"59","author":"JE Revuz","year":"2008","unstructured":"Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case\u2013control studies. J Am Acad Dermatol. 2008;59(4):596\u2013601.","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"504_CR8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","volume":"35","author":"GB Jemec","year":"1996","unstructured":"Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996;35(2 Pt 1):191\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"1062","key":"504_CR9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/postgradmedj-2013-131994","volume":"90","author":"DN Dufour","year":"2014","unstructured":"Dufour DN, Emtestam L, Jemec GB. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med J. 2014;90(1062):216\u201321.","journal-title":"Postgrad Med J"},{"issue":"6","key":"504_CR10","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/bjd.14038","volume":"173","author":"DM Saunte","year":"2015","unstructured":"Saunte DM, Boer J, Stratigos A, Szepietowski JC, Hamzavi I, Kim KH, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015;173(6):1546\u20139.","journal-title":"Br J Dermatol"},{"issue":"10","key":"504_CR11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","volume":"21","author":"HH van der Zee","year":"2012","unstructured":"van der Zee HH, Laman JD, Boer J, Prens EP. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol. 2012;21(10):735\u20139.","journal-title":"Exp Dermatol"},{"issue":"4","key":"504_CR12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","volume":"60","author":"A Alikhan","year":"2009","unstructured":"Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60(4):539\u201361.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"504_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2133.2006.07556.x","volume":"156","author":"EJ Giamarellos-Bourboulis","year":"2007","unstructured":"Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C, Mouktaroudi M, Spyridaki E, Baziaka F, et al. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol. 2007;156(1):51\u20136.","journal-title":"Br J Dermatol"},{"issue":"1","key":"504_CR14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5070\/D39D26366C","volume":"9","author":"NS Scheinfeld","year":"2003","unstructured":"Scheinfeld NS. A case of dissecting cellulitis and a review of the literature. Dermatol Online J. 2003;9(1):8.","journal-title":"Dermatol Online J"},{"issue":"4","key":"504_CR15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","volume":"56","author":"P Wolkenstein","year":"2007","unstructured":"Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol. 2007;56(4):621\u20133.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"504_CR16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2340\/00015555-1082","volume":"91","author":"S Esmann","year":"2011","unstructured":"Esmann S, Jemec GB. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol. 2011;91(3):328\u201332.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"504_CR17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-0866","volume":"90","author":"L Matusiak","year":"2010","unstructured":"Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol. 2010;90(3):264\u20138.","journal-title":"Acta Derm Venereol."},{"issue":"4","key":"504_CR18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","volume":"27","author":"AJ Onderdijk","year":"2013","unstructured":"Onderdijk AJ, van der Zee HH, Esmann S, Lophaven S, Dufour DN, Jemec GB, et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2013;27(4):473\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"504_CR19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaad.2016.01.001","volume":"74","author":"JS Kirby","year":"2016","unstructured":"Kirby JS. Qualitative study shows disease damage matters to patients with hidradenitis suppurativa. J Am Acad Dermatol. 2016;74(6):1269\u201370.","journal-title":"J Am Acad Dermatol"},{"issue":"3 Suppl","key":"504_CR20","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.12788\/j.sder.0093","volume":"33","author":"A Menter","year":"2014","unstructured":"Menter A. Recognizing and managing comorbidities and complications in hidradenitis suppurativa. Semin Cutan Med Surg. 2014;33(3 Suppl):S54\u20136.","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"504_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaad.2009.02.013","volume":"61","author":"F Canoui-Poitrine","year":"2009","unstructured":"Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol. 2009;61(1):51\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"504_CR22","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","volume":"71","author":"J Shlyankevich","year":"2014","unstructured":"Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case\u2013control analysis. J Am Acad Dermatol. 2014;71(6):1144\u201350.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"504_CR23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40265-015-0516-5","volume":"76","author":"IE Deckers","year":"2016","unstructured":"Deckers IE, Prens EP. An update on medical treatment options for hidradenitis suppurativa. Drugs. 2016;76(2):215\u201329.","journal-title":"Drugs"},{"issue":"29","key":"504_CR24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"30","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhasz I, et al. European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol. 2015;30(29):619\u201344.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"504_CR25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","volume":"17","author":"W Gulliver","year":"2016","unstructured":"Gulliver W, Zouboulis CC, Prens E, Jemec GB, Tzellos T. Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord. 2016;17(3):343\u201351.","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"504_CR26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1524-4725.2011.02186.x","volume":"38","author":"LZ Ellis","year":"2012","unstructured":"Ellis LZ. Hidradenitis suppurativa: surgical and other management techniques. Dermatol Surg. 2012;38(4):517\u201336.","journal-title":"Dermatol Surg"},{"key":"504_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16132","author":"AB Kimball","year":"2019","unstructured":"Kimball AB, Crowley JJ, Papp K, Calimlim B, Duan Y, Fleischer AB, et al. Baseline patient-reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice. J Eur Acad Dermatol Venereol. 2019. https:\/\/doi.org\/10.1111\/jdv.16132.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"504_CR28","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/jid.2012.472","volume":"133","author":"F Canoui-Poitrine","year":"2013","unstructured":"Canoui-Poitrine F, Le Thuaut A, Revuz JE, Viallette C, Gabison G, Poli F, et al. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. J Investig Dermatol. 2013;133(6):1506\u201311.","journal-title":"J Investig Dermatol"},{"issue":"1","key":"504_CR29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","volume":"133","author":"BG Vazquez","year":"2013","unstructured":"Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted county, Minnesota. J Investig Dermatol. 2013;133(1):97\u2013103.","journal-title":"J Investig Dermatol"},{"issue":"10","key":"504_CR30","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/jid.2012.162","volume":"132","author":"AE Pink","year":"2012","unstructured":"Pink AE, Simpson MA, Desai N, Dafou D, Hills A, Mortimer P, et al. Mutations in the gamma-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa). J Investig Dermatol. 2012;132(10):2459\u201361.","journal-title":"J Investig Dermatol"},{"issue":"9","key":"504_CR31","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","volume":"23","author":"J Revuz","year":"2009","unstructured":"Revuz J. Hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2009;23(9):985\u201398.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"504_CR32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000018126","volume":"198","author":"A Konig","year":"1999","unstructured":"Konig A, Lehmann C, Rompel R, Happle R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology. 1999;198(3):261\u20134.","journal-title":"Dermatology"},{"issue":"4","key":"504_CR33","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","volume":"161","author":"K Sartorius","year":"2009","unstructured":"Sartorius K, Emtestam L, Jemec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161(4):831\u20139.","journal-title":"Br J Dermatol"},{"issue":"5","key":"504_CR34","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjd.14024","volume":"173","author":"T Tzellos","year":"2015","unstructured":"Tzellos T, Zouboulis CC, Gulliver W, Cohen AD, Wolkenstein P, Jemec GB. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2015;173(5):1142\u201355.","journal-title":"Br J Dermatol"},{"issue":"5","key":"504_CR35","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jid.2016.11.040","volume":"137","author":"A Egeberg","year":"2017","unstructured":"Egeberg A, Jemec GBE, Kimball AB, Bachelez H, Gislason GH, Thyssen JP, et al. Prevalence and risk of inflammatory bowel disease in patients with hidradenitis suppurativa. J Investig Dermatol. 2017;137(5):1060\u20134.","journal-title":"J Investig Dermatol"},{"issue":"8","key":"504_CR36","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.jid.2016.04.003","volume":"136","author":"G Shalom","year":"2016","unstructured":"Shalom G, Freud T, Ben Yakov G, Khoury R, Dreiher J, Vardy DA, et al. Hidradenitis suppurativa and inflammatory bowel disease: a cross-sectional study of 3,207 patients. J Investig Dermatol. 2016;136(8):1716\u20138.","journal-title":"J Investig Dermatol"},{"issue":"7","key":"504_CR37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jamadermatol.2018.0878","volume":"154","author":"A Garg","year":"2018","unstructured":"Garg A, Hundal J, Strunk A. Overall and subgroup prevalence of crohn disease among patients with hidradenitis suppurativa: a population-based analysis in the United States. JAMA Dermatol. 2018;154(7):814\u20138.","journal-title":"JAMA Dermatol"},{"issue":"9","key":"504_CR38","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ad.2015.06.005","volume":"106","author":"A Martorell","year":"2015","unstructured":"Martorell A, Garcia FJ, Jimenez-Gallo D, Pascual JC, Pereyra-Rodriguez J, Salgado L, et al. Update on hidradenitis suppurative (part II): treatment. Actas Dermosifiliogr. 2015;106(9):716\u201324.","journal-title":"Actas Dermosifiliogr"},{"issue":"8","key":"504_CR39","first-page":"743","volume":"11","author":"A Kurek","year":"2013","unstructured":"Kurek A, Johanne Peters EM, Sabat R, Sterry W, Schneider-Burrus S. Depression is a frequent co-morbidity in patients with acne inversa. J Dtsch Dermatol Ges. 2013;11(8):743\u201350.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"504_CR40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jdv.12567","volume":"29","author":"E Shavit","year":"2015","unstructured":"Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2015;29(2):371\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"41","key":"504_CR41","first-page":"664","volume":"106","author":"GP Hammer","year":"2009","unstructured":"Hammer GP, du Prel JB, Blettner M. Avoiding bias in observational studies: part 8 in a series of articles on evaluation of scientific publications. Dtsch Arztebl Int. 2009;106(41):664\u20138.","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"504_CR42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2340\/00015555-2513","volume":"97","author":"B Horvath","year":"2017","unstructured":"Horvath B, Janse IC, Blok JL, Driessen RJ, Boer J, Mekkes JR, et al. Hurley staging refined: a proposal by the Dutch Hidradenitis Suppurativa Expert Group. Acta Derm Venereol. 2017;97(3):412\u20133.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"504_CR43","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/bjd.15748","volume":"177","author":"CC Zouboulis","year":"2017","unstructured":"Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, et al. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol. 2017;177(5):1401\u20139.","journal-title":"Br J Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-020-00504-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-020-00504-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-020-00504-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T19:20:00Z","timestamp":1665861600000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-020-00504-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,19]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["504"],"URL":"https:\/\/doi.org\/10.1007\/s40257-020-00504-4","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,19]]},"assertion":[{"value":"19 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"EP Prens has received honoraria from AbbVie, Amgen, Celgene, Janssen, Galderma, Novartis, and Pfizer for participation as a speaker and on advisory boards and received investigator-initiated grants (paid to the Erasmus MC) from AbbVie, AstraZeneca, Janssen, and Pfizer. AM Lugo-Somolinos has received honoraria from AbbVie, Castle Creek, Celgene, Centocor, Janssen, Eli Lilly, Novartis, Pfizer, Regeneron, Scioderm, and Stiefel for participation as an investigator. AS Paller has received grants (to Northwestern University) from AbbVie, Anaptysbio, Eli Lilly, Galderma, Incyte, Leo, Janssen, Novartis, and Regeneron for investigator services, and honoraria from AbbVie, Amgen, Asana, Dermavant, Dermira, Eli Lilly, Forte, Galderma, Leo, Matrisys, Menlo, Mophosys\/Galapagos, Novartis, Pfizer, Regeneron, Sanofi-Genzyme, and UCB for consulting services. F Kerdel has received honoraria from AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Leo, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, and Stiefel for participation as a speaker and grants from AbbVie, Amgen, AstraZeneca, Celgene, Dr. Reddy\u2019s, Eli Lilly, Janssen, Novartis, Ortho Dermatologics, Pfizer, Regeneron, UCB, X-Biotech, and XOMA, for participation as an investigator. Y Duan, HD Teixeira, and M Longcore have received a salary as AbbVie employees and may have also received stocks and\/or stock options. AB Kimball has received honoraria as a consultant and grants as an investigator from Janssen, AbbVie, Lilly, Novartis, Pfizer, and UCB and fellowship funding from Janssen and AbbVie.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethics committee, institutional review board, and\/or other local approval processes in the specific country or region of the study site and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients and\/or their legal guardians voluntarily signed an informed consent, approved by an institutional review board or ethics committee as applicable, according to local law.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"AbbVie Inc. funded this study and participated in the study design; study research; collection, analysis, and interpretation of data; and writing, reviewing, and approving of this publication. All authors had access to the data and participated in the development, review, and approval of and the decision to submit this publication.\u00a0AbbVie Inc. funded Open Access of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}